Revance
Price & Volume
Stats
See moreOpen | $5.72 |
Previous Close | $5.80 |
Day Range | $5.65-$5.82 |
52W Range | $2.30-$9.74 |
Market Cap | $604.2M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $251.1M |
Revenue Growth (YoY) | 20.2% |
Gross Profit (12 Mos) | -$20.3M |
Diluted EPS | -$3.43 |
News
See moreYahoo Finance • 12 months ago
Q3 2023 Revance Therapeutics Inc Earnings Call
Yahoo Finance • last year
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeutics, Inc. - RVNC
Yahoo Finance • last year
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeutics, Inc. - RVNC
Yahoo Finance • last year
13 Stocks to Buy with Exponential Growth
About
CEO | Mr. Mark J. Foley |
CFO | Mr. Tobin C. Schilke |
Address | 1222 Demonbreun Street, Nashville, TN, United States, 37203 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 597 |
